Role of combination of PET-CT and tumor markers in assessment of response in advanced non-small cell lung cancer after chemotherapy and radiotherapy / 国际肿瘤学杂志

ABSTRACT

After chemoradiation therapy, tumor tissue metabolism changes earlier than its shape in advanced non-small cell lung cancr (NSCLC). Therefore, Positron emission tomography-computed tomography (PET-CT) can early assess the therapeutic efficacy and prognosis. But PET-CT might bring up some false negative or false positive outcome, while combined with the tumor markers, more accurate assessments of therapeutic efficiency and prognosis could be made for advanced(NSCLC).